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Metastasis followed by the tumor development is the primary cause of death for cancer 
patients. However, the underlying molecular mechanisms of how the growth of tumor 
resulted in the immune suppression, especially at the blood-enriched organ such as 
liver, were largely unknown. In this report, we studied the liver immune response of 
tumor-bearing (TB) mice using concanavalin A (Con A)-induced hepatitis model. We 
demonstrated that TB mice displayed an immune suppression phenotype, with attenu-
ated alanine aminotransferase levels and liver damage upon Con A treatment. We also 
elucidated that large amounts of myeloid-derived suppressor cells (MDSCs) being influx 
into the liver in TB mice and these MDSCs were essential for liver immune suppression 
through both depletion and reconstitution approaches. We further determined that these 
MDSCs selectively suppressed the IFN-γ production deriving from NKT cells through 
membrane-bound transforming growth factor β (TGF-β). Finally, we defined a tumor- 
derived TGF-β-triggered CXCL1/2/5- and CXCR2-dependent recruitment of MDSC into 
the liver. In summary, our results defined a novel mechanism of liver immune suppression 
triggered by growing living tumor and provided possible therapeutic targets against 
these MDSCs.
Keywords: remote tumor, MDsc, TgF-β, cXcr2, liver immune suppression
inTrODUcTiOn
Cancer continues to represent global health problems in human beings. Emerging evidence has 
shown that tumors can escape immune surveillance via producing an immune-suppressive environ-
ment in the development and progression of tumor metastasis. Tumor-induced immunosuppression 
has been recognized as an essential element in tumor progression (1). Research has shown that cancer 
cells consistently induce local immunosuppression and then create systemic immunosuppression 
via immune-suppressive cells and cytokines (2). However, the underlying molecular mechanisms 
Abbreviations: Con A, concanavalin A; MDSCs, myeloid-derived suppressor cells; TGF-β, transforming growth factor β; 
CXCR, CXC chemokine receptor; CXCL, CXC chemokine ligand; WT, wild type; TB, tumor bearing.
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are not clear. Recent reports showed that immune responses in 
cancer patients are negatively regulated by immunosuppressive 
cells, mainly T regulatory cells (Tregs) and myeloid-derived 
suppressor cells (MDSCs), which suppress exuberant immune 
system activation and promote immunologic tolerance (3, 4). 
Lines of studies further defined that MDSCs can modulate the de 
novo development and induction of Tregs (5). MDSCs are known 
to synergize with Tregs to prevent tumor immunity (6). However, 
the mechanisms of remote tumor cell-induced organ tolerance 
still require further clarification.
MDSCs, a heterogeneous of immune cells including immature 
DCs, macrophages, granulocytes, and other myeloid cells in early 
stages of their differentiation, usually express CD11b, CD33, and 
low levels of leukocyte antigen-DR in humans or CD11b and Gr1 
in mice (7, 8). As reported by Gabrilovich and other scientists, as 
MDSC accumulated during advanced cancer stages, they exerted 
an immune-regulatory role and could inhibit many immune 
cells: CD4+, CD8+, NK, Tregs, etc. (3, 9, 10). Several mechanisms 
of MDSC suppressive functions have been described, includ-
ing l-arginine depletion by the enzymes arginase 1 (Arg-1) or 
inducible nitric oxide synthase (iNOS) and generation of reactive 
oxygen species (ROS) (11–13). Moreover, MDSCs also secreted 
many immune-suppressive cytokines, such as IL-6, IL-10, and 
transforming growth factor β (TGF-β) (14). However, other 
mechanisms may have not been identified.
The liver is a blood-enriched organ and contains abundant 
innate and adaptive immune cell subtypes. MDSCs in hepatocel-
lular carcinoma patients regulate the innate system and contribute 
to immune suppressor networks (15). However, liver tolerance 
mechanisms induced by remote tumor inoculated subcutane-
ously (s.c.) outside the liver are uncertain.
A T cell-dependent experimental hepatitis in mice induced 
by concanavalin A (Con A) was reported in 1990 by Tiegs (16). 
Con A-induced acute hepatitis is well documented and imitates 
human autoimmune diseases. IFN-γ plays a critical role in T 
cell-dependent liver injury in mice initiated by Con A (17, 18). 
In our previous studies, IFN-γ is critical for tumor immunity and 
γδ T cells provide the early source of IFN-γ (19). In the model of 
Con A-induced hepatitis, NK or NKT cells detrimented the liver 
damage trough making IFN-γ, which was negatively regulated by 
γδT cells (20). In this study, we intend to investigate the immune 
tolerance in the liver of tumor-bearing (TB) mice using Con 
A-induced hepatitis as the readout of liver immune response.
The TGF-β has three isoforms in mammalian animals, 
including TGF-β1, TGF-β2, and TGF-β3 that exert diverse roles 
in controlling cell proliferation, differentiation, wound heal-
ing, immune systems, and some pathological processes, e.g., 
fibrosis and cancer (21, 22). TGF-β1 is most highly expressed 
by immune cells, and a malfunction in this signaling pathway 
resulted in tumorigenesis (23). Increased TGF-β production has 
been reported in both human cancer patients and animal models, 
which is usually considered as a negative prognostic indicator 
(24). Pathological forms of TGF-β signaling promote tumor 
evasion of immune surveillance, tumor growth, and metastasis. 
Decreased TGF-β signaling reduces formation of gastrointestinal 
tumors (25). Our previous study also showed that tumor-derived 
TGF-β contributed to both tumor growth and tumor immunity 
(26). TGF-β exists in two forms: membrane bounded and solu-
ble (27). However, the role of tumor-derived TGF-β in MDSC 
recruitment regulation was unclear.
In this report, we investigated the mechanisms of liver immune 
suppression induced by remote tumor cells. We demonstrated 
that growing tumor cells triggered the influx of MDSCs into the 
liver, and these MDSCs then suppressed the function of NKT cells 
through their membrane-bound TGF-β.
MaTerials anD MeThODs
Mice
C57BL/6J [wild-type (WT)] mice were purchased from the Vital 
River Laboratory Animal Technology Co., Ltd. (Beijing, China). 
All mice were kept in specific pathogen-free conditions in the 
animal facility at Nankai University (Tianjin, China) and used at 
6–10 weeks of age. CXCR2−/− mice (on the C57BL/6J background) 
were purchased from Jackson Laboratory (Bar Harbor, ME, USA) 
via Nanjing Medicine University. All animal procedures were 
approved by the Nankai University Experimental Animal Ethics 
Committee.
cell lines
B16-F0 (B16), TGF-β sh RNA-transfected stable B16-F0 
(shB16) (26), and EL-4 cells were cultured in DMEM (Hyclone, 
ThermoFisher, Beijing, China) with 10% FBS and were main-
tained in a humidified incubator containing 5% CO2 at 37°C.
Mice Model
Fulminant hepatitis was induced by Con A (10  mg/kg body 
weight) injected via tail vein. Tissue H&E stain and serum alanine 
aminotransferase (ALT) levels were measured to evaluate the 
mice model. TB mice were prepared by injecting tumor cells s.c. 
at 1 × 106 per mouse. Tumor sizes were measured every 2 days, 
and Con A was treated on 15 days posttumor inoculation.
reagents
Concanavalin A, catalase, and l-N6-(1-iminoethyl) lysine 
dihydrochloride (l-NIL) were purchased from Sigma (Sigma-
Aldrich). N-hydroxy-nor-arginine (nor-NOHA) was purchased 
from Caymen Chemical (MI, USA). Recombinant mouse (rm) 
TGF-β was purchased from R&D Systems (Minneapolis, MN, 
USA). FITC-conjugated CD11b (clone M1/70), PE-conjugated 
CD11b (clone M1/70), APC-conjugated Gr-1 (clone RB68C5), 
FITC-conjugated CD3 (clone 145-2C11), APC-conjugated NK1.1 
(clone PK136), and PE-conjugated IFN-γ (clone XMG1.2) were 
purchased from BD Biosciences (San Jose, CA, USA). Ionomycin, 
GolgiStop, and PMA were purchased from BD Biosciences (San 
Jose, CA, USA). Anti-TGF-β1 Ab (clone 1D11) was obtained 
from R&D Systems (Minneapolis, MN, USA). Anti-IL-6 mAb 
(clone MP5-20F3), Anti-IL6R mAb (clone 15A7), neutralizing 
anti-Gr-1 Ab (clone RB68C), and anti-CD25 Ab (clone PC-61.5.3) 
were purchased from Tianjin Sungene (Tianjin, China).
histology
For histological analysis, mice livers with hepatitis were fixed 
with 4% (w/v) paraformaldehyde and then embedded in paraffin. 
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Sections (4  μm) that had been deparaffinized and rehydrated 
were stained with H&E.
elisa
Mouse IFN-γ (cat. 430805), TNF-α (cat. 430905), IL-12 (cat. 
433605), IL-4 (cat. 431105), and IL-6 (cat. 431305) ELISA kits 
were purchased from BioLegend (San Diego, CA, USA), and 
ELISA was performed according to the manufacturer’s protocols.
Quantitative rT-Pcr (qrT-Pcr)
Total RNA was extracted from tissues or cells with Trizol reagent 
from Life Technologies (Carlsbad, CA, USA). qRT-PCR analyses 
for the mRNA of CXCRs and CXCLs were performed by using 
PrimeScript RT-PCR kits (Takara, Dalian, China). The mRNA 
level of glyceraldehyde-3-phosphate dehydrogenase was used as 
an internal control.
The primer sequences used are listed in Table S1 in Supple-
mentary Material.
isolation of liver Mononuclear cells (Mncs)
Liver MNCs were isolated and purified by the method of 
Faheina-Martins et  al. (28), with some modifications. Briefly, 
homogenized liver cells were resuspended in 40% percoll (GE 
Healthcare), gently overlayed onto 70% percoll, and centrifuged 
for 30 min at 1,260 × g. Finally, purified MNCs were collected 
from the interface for further study.
intracellular staining and Flow cytometry
Surface staining was performed with the corresponding fluo-
rescence-labeled surface Abs. For intracellular IFN-γ staining, 
liver MNCs were obtained from the liver of mice and stimulated 
with PMA (50 ng/ml) and ionomycin (1 µg/ml) in the presence 
of GolgiStop for 6 h. Cells were then fixed, permeabilized, and 
stained as previously described (29).
Detection of iFn-γ
A total of 1 × 106/mL WT hepatic NKT cells (>95% pure, Figure 
S2 in Supplementary Material) were cultured alone or with 
TB hepatic MDSCs (>95% pure, Figure S2 in Supplementary 
Material) at a1:1 ratio or with reagents (0.5  ng/ml TGF-β1 or 
10 ng/ml anti-TGF-β1 Ab) for 6 h. Then, NKT cells were stimu-
lated with 25 ng/ml PMA and 1 µg/ml ionomycin for 18 h. IFN-γ 
concentrations in the supernatants were determined by ELISA kit 
from BioLegend (San Diego, CA, USA).
Detection of rOs
The levels of intracellular ROS were detected by a ROS assay kit 
(Beyotime Biotech, China) following the manufacturer’s pro-
tocol. Briefly, liver MNCs isolated from both WT and TB mice 
were washed twice with PBS and incubated with DCFH-DA 
(10 µmol/l) at 37°C for 40 min and then analyzed through flow 
cytometry.
adoptive Transfer or Depletion of MDscs 
and Tregs
Purified MDSCs or Tregs were intravenously (i.v.) injected into 
WT mice (5 × 105 per mouse). For MDSC depletion, 0.2 mg of 
anti-Gr-1 Ab (RB6-8C5) was intraperitoneally (i.p.) injected into 
TB mice. Twelve hours later, mice were challenged by Con A. 
For Treg depletion, 0.2 mg of anti-CD25 Ab (PC-61.5.3) was i.p. 
injected into TB mice. Forty-eight hours later, mice were chal-
lenged by Con A. The cell transfer and depletion efficiency were 
confirmed by flow cytometry.
statistics
Data are presented as mean  +  SEM. Statistical significance 
between two groups was evaluated using a two-tailed unpaired 
Student’s t-test. Statistically significant data are indicated by 
asterisks (*p < 0.05, **p < 0.01, and ***p < 0.001).
resUlTs
TB Mice showed alleviated con 
a-induced Fulminant hepatitis
To study the role of growing living tumor cells in liver immune 
responses, C57BL/6J mice (WT mice) were inoculated s.c. either 
with 1 × 106 B16 or EL4 cells to generate TB mice (TB-B16 or 
TB-EL4 mice), respectively, followed by Con A challenge (10 mg/
kg body weight) 15  days posttumor inoculations. Serum ALT 
levels were measured at indicated time points (Figure  1A). 
Interestingly, TB mice were highly resistant to Con A and showed 
decreased serum ALT levels (Figure  1B) and attenuated liver 
damage (Figure 1C) when compared with WT mice. TB (B16) 
mice showed a more protective role in Con A-induced hepatitis; 
therefore, we used TB (B16) mice models in subsequent studies. 
Moreover, the relationship between ALT levels and tumor sizes 
were also analyzed. ALT levels were negatively correlated with 
tumor sizes (Figure  1D), but not with times of tumor growth 
(data not shown). These findings indicated that TB mice had a 
significant resistance against Con A-induced fulminant hepatitis.
reduced iFn-γ and Mediated 
inflammation in TB (B16) Mice
To define the mechanisms of liver immune suppression induced 
by remote tumor cells in TB (B16) mice, inflammatory cytokine 
levels of WT and TB (B16) mice were analyzed in sera samples 
collected at different time points post-Con A challenge (10 mg/
kg body weight). A remarkable cytokine storm was observed after 
Con A challenge in WT mice (Figure 2A). Notably, compared 
with TB (B16) mice, an extremely high level of IFN-γ reached 
its peak in WT mice at 2 h and steadily persisted for 12 h. These 
findings suggested that IFN-γ exerted a critical pathogenic role in 
mediating Con A-induced liver injuries.
To exclude the possibility that the protective role of tumor 
burden was due to an intrinsic decreased susceptibility to apop-
tosis independent of inflammation, the response of hepatocytes 
to activating anti-Fas antibody was evaluated. Fas expression was 
not changed between WT and TB (B16) mice with or without 
Con A treatment (Figure 2B). Injection of this antibody induced 
hepatocyte apoptosis due to Fas-FasL-mediated death signaling. 
Results showed that WT and TB (B16) mice showed similar ATL 
levels (Figure 2C) and liver damage (Figure 2D) following this 
antibody treatment. Therefore, hepatocytes of TB (B16) mice had 
similar response to Fas-FasL-mediated apoptosis.
FigUre 1 | alleviated concanavalin a (con a)-induced hepatitis in tumor-bearing (TB) mice. Sex- and age-matched C57BL/6 wild-type mice were either 
untreated or subcutaneously injected with B16 or EL4 tumor cells (1 × 106 cells/mouse) to prepare TB mice (TB-B16 or TB-EL4), respectively. On 15 days 
posttumor inoculations, these mice were challenged with Con A (10 mg/kg body weight). (a) Serum samples were collected at different time points post-Con A 
treatments and used for analysis of alanine aminotransferase (ALT) levels (n = 8). (B) Results from one representative experiment at the time point of 12 h 
posttreatment are shown. (c) Liver tissues collected at 12 h post-Con A treatments were fixed for hematoxylin and eosin staining, and one representative tissue 
staining is shown. Scale bars, 200 µm. (D) The relationship of serum ALT levels and tumor sizes was analyzed by SPSS, and results from one representative 
experiment are shown (R2 = −0.5863, p = 0.0170).
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Taken together, these findings revealed that alleviated liver 
injury in TB (B16) mice is dependent on IFN-γ-mediated inflam-
mation, but not due to Fas-FasL signaling.
MDscs, not Tregs, exerted suppressive 
Function in liver of TB (B16) Mice
To further elucidate the liver immune environment in TB (B16) 
mice, liver MNCs were isolated from either WT or TB (B16) mice, 
and immune-suppressive cells, MDSCs, and Tregs were analyzed 
through flow cytometry. Both percentages and numbers of 
MDSCs and Tregs in TB (B16) mice were remarkably higher than 
in WT mice (Figures 3A,C). Meanwhile, one representative FACS 
staining showed that MDSCs (Figure 3B) and Tregs (Figure 3D) 
were accumulated in TB (B16) mice livers. Therefore, we assumed 
that alleviated inflammation and liver injuries in TB (B16) mice 
were due to hepatic MDSCs and/or Tregs accumulation.
FigUre 2 | induction of immune suppression in tumor-bearing (TB) (B16) mice. (a) Sex- and age-matched wild-type (WT) mice were either untreated or 
inoculated with B16 tumor cells as described above (named TB-B16), followed by concanavalin A (Con A) injections. Serum samples were collected at 0, 2, 4, 6, 8, 
12, and 24 h post-Con A treatments and used for determining cytokine levels by ELISA (n = 6). Results shown are one of three independent experiments. (B) Livers 
of WT and TB mice were harvested before and 2 h after Con A challenge. Fas mRNA levels were determined via quantitative real-time PCR (n = 3). (c) A total of 
1 mg/kg anti-Fas (clone Jo2) were injected intravenously into WT and TB mice. At 12 h after injections, serum alanine aminotransferase levels were measured 
(n = 6). (D) Liver tissues were fixed for hematoxylin and eosin staining, and one representative tissue staining is shown. Scale bars, 200 µm.
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To further elucidate the underlying mechanisms of immune-
suppressive cells in protecting TB mice from liver injury, 
depletion and adoptively transfer experiments were performed. 
To deplete Tregs, anti-CD25 antibody (200  μg/mouse) was 
injected 48  h (Figure S1C in Supplementary Material) prior 
to Con A injection and serum ALT levels were detected 12 h 
post-Con A injection. To deplete MDSCs, TB (B16) mice were 
treated with anti-Gr-1 antibody (200 μg/mouse) 24 h (Figure 
S1A in Supplementary Material) prior to Con A injection and 
serum ALT levels were detected 12 h post-Con A injection. We 
demonstrated that it could restore ALT level only by deplet-
ing MDSCs, but not Tregs (Figure  3E). To further identify 
MDSC immune-suppressive function, either 5 ×  105 MDSCs 
or Tregs were isolated from the livers of TB (B16) mice and i.v. 
transferred into WT mice. MDSCs were recruited into livers 
3  h (Figure S1B in Supplementary Material) posttransfer and 
Tregs at 6 h (Figure S1D in Supplementary Material) posttrans-
fer. Thus, we injected Con A at these time points, respectively. 
Serum samples were collected 12 h post-Con A injection, and 
ALT levels were detected and found that adoptively transferred 
TB (B16) mice hepatic MDSCs, not Tregs, could protect against 
Con A-induced hepatitis (Figure  3F). These results further 
supported a critical role of MDSCs in tumor cell-induced liver 
immune suppression.
iFn-γ Production of nKT cells, but not 
cD4+ T cells, Was inhibited by MDscs
Consistent with other reports, Con A-induced hepatitis is 
related to IFN-γ production in the liver (18, 30). To elucidate 
the cellular source of IFN-γ, livers of WT and TB (B16) mice 
were isolated 12 h post-Con A injection, and IFN-γ production 
of NKT and CD4+ T cells was analyzed through flow cytometry. 
IFN-γ production of NKT, not CD4+ T cells, were inhibited in 
the liver of TB (B16) mice challenged by Con A (Figure 4A). 
One typical flow cytometry plot is shown (Figure 4B). To further 
identify whether the inhibition of IFN-γ production of NKT 
cells was due to accumulated MDSCs in livers of TB (B16) mice, 
we depleted MDSCs of TB (B16) mice by anti-Gr-1 antibody or 
transferred 5 × 105 TB (B16) hepatic MDSCs into WT mice fol-
lowed by Con A injection at indicated times. Livers were isolated 
FigUre 3 | increased liver immune-suppressive cells in the liver of tumor-bearing (TB) mice. Sex- and age-matched wild-type (WT) mice were either 
untreated or inoculated with 1 × 106 B16 cells. Fifteen days postinoculation, liver mononuclear cells were prepared and analyzed through flow cytometry (n = 6). (a) 
The percentage and absolute number of CD11b+Gr1+ myeloid-derived suppressor cells (MDSCs) (mean ± SEM) are shown. (B) One representative FACS staining in 
panel (a) is shown. (c) The percentage and absolute number of CD4+Foxp3+ T regulatory cells (Tregs) (mean ± SEM) are shown. (D) One representative FACS 
staining in panel (c) is shown. (e) Depletion of MDSC, but not Tregs, restored concanavalin A (Con A)-induced hepatitis in TB mice. TB mice were either untreated 
or intraperitoneally injected with 0.2 mg anti-Gr1 (clone RB68C5) or anti-CD25 (clone PC-61.5.3) prior to Con A treatment as described in Section “Materials and 
Methods.” Serum samples collected at 12 h post-Con A treatment were used for alanine aminotransferase (ALT) detection, and results from one typical experiment 
are shown (mean ± SEM, n = 7). (F) Adoptive transfer of MDSCs, but not Tregs, from TB mice protected WT mice against Con A-induced hepatitis. Sex- and 
age-matched WT mice were either untreated or adoptively transferred with 5 × 105 CD11b+Gr1+ cells or CD4+CD25+ Treg cells from TB mice via intravenous 
injection prior to Con A injection. Serum samples collected at 12 h post-Con A treatment were used for analyzing ALT levels. Results from one representative 
experiment are shown (mean ± SEM, n = 5). Data represent at least three independent experiments with similar results.
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12 h post-Con A challenge and stimulated with 50 ng/ml PMA 
and 1 µg/ml ionomycin in the presence of GolgiStop for 6 h, and 
IFN-γ production of CD4+ and NKT cells was analyzed by flow 
cytometry. We found that IFN-γ production of NKT cells was 
restored after MDSC depletion (Figure  4C), as representative 
FACS plot is shown (Figure 4D). Interestingly, IFN-γ produc-
tion of CD4+ T cells was not changed (Figures 4C,D). Similarly, 
adoptive transferring MDSCs also suppressed IFN-γ production 
FigUre 4 | continued
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FigUre 4 | continued 
iFn-γ production of nKT, not cD4+ T cells, was inhibited by myeloid-derived suppressor cells (MDscs). (a) Wild-type (WT) and tumor-bearing (TB) mice 
were challenged by concanavalin A (Con A) (10 mg/kg body weight) 15 days post-B16 injections; 12 h later, mice were sacrificed and liver mononuclear cells were 
isolated. Afterward, intracellular IFN-γ intracellular staining was performed as described in Section “Materials and Methods,” and cells were analyzed by flow 
cytometry (n = 5). (B) One typical flow cytometry plot in panel (a) is shown. (c) MDSC depletion restored IFN-γ production of NKT cells. WT and TB mice were 
challenged by Con A 24 h after anti-Gr1 treatment. Then, 12 h later, mice were sacrificed and IFN-γ intracellular staining was performed, and cells were analyzed by 
flow cytometry (n = 5). (D) One typical flow cytometry plot in panel (c) is shown. (e) MDSC transfer inhibited IFN-γ production of NKT cells. 5 × 105 TB MDSCs 
were intravenously transferred into WT mice, followed by Con A challenge (10 mg/kg), and 12 h later, livers were isolated. IFN-γ intracellular staining was performed, 
and cells were analyzed by flow cytometry (n = 5). (F) One typical flow cytometry plot in panel (e) is shown.
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only by NKT cells, not by CD4+ T cells (Figures  4E,F). Our 
results thus revealed that IFN-γ production of NKT, not CD4+ 
T cells, was inhibited by MDSCs accumulated in the liver of TB 
(B16) mice.
MDscs inhibited iFn-γ Production  
of nKT cells through Membrane-Bound 
TgF-β
To further investigate the underlying mechanisms for impair-
ment of NKT cell function by hepatic MDSCs in TB (B16) mice, 
we co-cultured WT hepatic NKT with MDSCs sorted from 
livers of TB (B16) mice at a 1:1 ratio or at various conditions 
for 6 h and then stimulated with 25 ng/ml PMA plus 1 µg/ml 
ionomycin for 18 h. It showed that co-culturing with TB (B16) 
MDSCs inhibited IFN-γ production of NKT cells (Figure 5A). To 
identify whether soluble molecules or cell–cell interactions were 
involved in this process, we incubated NKT cells and MDSCs 
in the transwell system (0.4 µM). The downregulation of IFN-γ 
production of NKT cells by MDSCs was lost in the transwell 
system (Figure  5A), suggesting that MDSC-mediated inhibi-
tion of NKT cells was due to cell–cell contact. As TGF-β1 is an 
important suppressive cytokine produced by MDSCs (31), we 
investigated whether MDSCs could express membrane-bound 
TGF-β1, and if so, whether membrane-bound TGF-β1 was 
involved in the process. Neutralization of TGF-β1 in the co-
culture system restored IFN-γ production (Figure 5A), whereas 
the exogenous recombinant TGF-β1 supplement in the culture 
system had no significant suppressive effect. Meanwhile, we also 
detected other MDSC-derived suppressive factors, Arg-1, iNOS, 
and ROS. Arg-1 and iNOS expression were not changed between 
WT and TB (B16) mice (Figure 5B); however, ROS expression 
elevated in TB (B16) mice livers (Figure 5C). To verify whether 
Arg-1, iNOS, or ROS participated in the inhibition of NKT by 
MDSCs, we co-cultured WT NKT with MDSCs sorted from liv-
ers of TB (B16) mice at a 1:1 ratio in the absence or presence of 
specific inhibitors of Arg-1, ROS, or iNOS: nor-NOHA (1 mM), 
catalase (1,000 U/ml), or l-NIL (0.5 µM), respectively (32). We 
confirmed that Arg-1, iNOS, and ROS produced by MDSCs are 
not involved in suppressing IFN-γ production; this is because 
inhibitors against these suppressive factors could not restore the 
suppression of NKT cells by MDSCs in the co-culture system 
(Figure 5D). Therefore, we concluded that the membrane-bound 
TGF-β1 from MDSCs was responsible for the impairment of 
IFN-γ production of NKT cells.
MDscs recruited into liver via cXcr2 
signal Pathway
Results above revealed that MDSCs were critical for liver 
immune suppression in TB (B16) mice. CXCR-CXCL signal 
pathways have been reported to exert an important role in 
MDSC migration (33, 34). To further define the mechanisms 
of MDSC recruitment into liver, CXCRs and CXCLs expres-
sions in liver lymphocytes was analyzed via quantitative 
real-time PCR. Interestingly, CXCR2 expression was increased 
in TB (B16) mice (Figure  6A). Meanwhile, CXCR2 ligands, 
CXCL1, CXCL2, and CXCL5 expressions were also elevated in 
TB (B16) mice livers (Figure 6B). These findings suggested a 
hypothesis that MDSCs recruited into livers in TB (B16) mice 
via CXCR2 signaling. To test this hypothesis, CXCR2−/− mice 
were inoculated with B16 tumor cells. Interestingly, recruit-
ment of MDSCs into the liver was significantly impaired in 
CXCR2−/− TB (B16) mice (Figure  6C), and one example of 
representative FACS plot is shown (Figure  6D). Moreover, 
WT-TB and CXCR2−/− TB were challenged by Con A 15 days 
posttumor inoculations and found that CXCR2−/− TB (B16) 
mice partly restored sera ALT levels and liver damage 
(Figures  6E,F). Collectively, these results demonstrated that 
CXCL1/2/5-CXCR2 signaling is responsible for recruitment of 
MDSCs into the liver.
Tumor-Derived TgF-β-regulated MDsc 
recruitment into liver via regulating 
cXcls expression
Our previous research disclosed that tumor-derived TGF-β 
induced MDSCs migration into tumor sites (26). To investigate 
tumor-derived TGF-β effects in MDSC recruitment into liver 
and immune suppression conduction, sex- and age-matched 
WT mice were either untreated or inoculated with B16 cells or 
shRNA-transfected stable B16 cells prepared in our laboratory 
(26) (Figure S3A in Supplementary Material) (1  ×  106 cells/
mouse), which named TB (B16) or TB (sh B16), respectively 
(Figure S3B in Supplementary Material). On day 15 posttumor 
inoculations, these mice were challenged with Con A and levels 
of ALT in sera at indicated time points ware analyzed. It was 
found that TB (sh B16) mice could restore sera ALT levels 
(Figure 7A). Moreover, TB (sh B16) mice showed a lower per-
centage of hepatic MDSCs than TB (B16) mice (Figure 7B). One 
typical staining is shown (Figure  7C). Therefore, we assumed 
that tumor-derived TGF-β regulated MDSC recruitment into 
FigUre 5 | Myeloid-derived suppressor cells (MDscs) inhibited iFn-γ production of nKT cells via membrane-bounded transforming growth factor β 
(TgF-β) in a cell contact-dependent manner. (a) Membrane-bound TGF-β is the main factor for suppression of NKT cell IFN-γ secretion. NKT cells 
(CD3+NK1.1+) were isolated from liver tissues of wild-type (WT) mice, co-cultured with MDSCs sorted from livers of tumor-bearing (TB) mice at the ratio of 1:1 under 
various conditions, including either transwell (0.4 µm) separation or in the presence of 10 ng/ml anti-TGF-β1 mAb or 0.5 ng/ml rmTGF-β1 for 6 h, and then cells 
were then stimulated with PMA (25 ng/ml) plus ionomycin (1 µg/ml). Eighteen hours later, supernatants were harvested for determination of IFN-γ levels using ELISA 
kit. Results (mean ± SEM) of triplicated wells from one representative experiment are shown. (B) Expression levels of arginase 1 (Arg-1) and inducible nitric oxide 
synthase (iNOS) were not changed in liver tissues of TB mice. Livers were isolated from either WT or TB mice (day 15 posttumor inoculation), and mRNA levels of 
Arg-1 and iNOS were determined via quantitative real-time PCR (n = 3). Results from one representative experiment are shown. (c) Reactive oxygen species (ROS) 
expression was increased in the liver of TB mice. Livers were isolated from either WT or TB mice 15 days posttumor inoculation. ROS levels were determined via 
ROS assay kit as described in Section “Materials and Methods” (n = 3). Results from one representative experiment are shown. (D) Arg-1, iNOS, and ROS inhibitors 
failed to restore IFN production of NKT cells in vitro. NKT cells were co-cultured with MDSCs isolated from the liver of TB mice at the ratio of 1:1 as described above 
in the absence or presence of various inhibitors, including N-hydroxy-nor-arginine (1 mM), catalase (1,000 U/ml), or l-NIL (0.5 µM) for 6 h. Then cells were stimulated 
with PMA plus ionomycin, and IFN-γ levels at the supernatant were determined using ELISA kit. Results from triplicated wells (mean ± SEM) are shown.
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their livers. To further investigate the underlying mechanisms 
of MDSC recruitment, CXCR2 ligands, CXCL1, CXCL2, and 
CXCL5 expressions in liver tissues of WT, TB (B16), and TB 
(sh B16) mice was analyzed via quantitative real-time PCR. 
CXCL1, CXCL2, and CXCL5 expressions in TB (B16) mice were 
remarkably higher than in TB (sh B16) mice (Figure 7D). These 
FigUre 6 | recruitment of myeloid-derived suppressor cells (MDscs) into tumor-bearing (TB) (B16) mice livers was cXcr2 mediated. (a) Liver 
mononuclear cells (MNCs) were isolated from either wild-type (WT) or TB mice 15 days posttumor inoculation, and mRNA levels of CXCRs were determined via 
quantitative real-time PCR (n = 3). (B) Liver tissues were isolated from either WT or TB mice 15 days posttumor inoculation, and mRNA levels of CXCRs were 
determined via quantitative real-time PCR (n = 3). (c) CXCR2-dependent liver recruitment of MDSC in TB mice. Sex- and age-matched WT mice and CXCR2−/− 
mice were either untreated or inoculated with B16 tumor cells to prepare TB mice as described above, and liver MNCs was prepared from the livers and then used 
for analyzing the percentage of CD11b+Gr1+ through flow cytometry (n = 6). (D) One representative FACS plot in panel (c) is shown. (e) Deficiency of CXCR2 
rendered susceptibility to Con A-induced liver damage in TB mice. Sex- and age-matched WT or CXCR2−/− mice were injected with B16 tumor cells, and on day 15 
posttumor inoculation, mice were challenged with concanavalin A (Con A). Serum samples collected at 12 h post-Con A injections were used for analyzing the levels 
of alanine aminotransferase (n = 6). (F) Liver tissues were fixed for hematoxylin and eosin staining, and one representative tissue staining is shown. Scale bars, 
200 µm.
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findings suggested a hypothesis that tumor-derived TGF-β 
upregulated CXCL1, CXCL2, and CXCL5 expressions and then 
regulated MDSC recruitment into the liver. To further define 
tumor-derived TGF-β-regulated recruitment of MDSCs into 
the liver, we injected i.p. 1 μg/mouse rmTGF-β into WT mice. 
We found that injection of rmTGF-β promoted recruitment of 
FigUre 7 | continued
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MDSC into the liver (Figures 7E,F). To further analyze mecha-
nism-mediated MDSCs recruitment, CXCR2 ligands expression 
was determined using quantitative real-time PCR and found 
that i.p. injection of rmTGF-β remarkably promoted CXCL1, 
CXCL2, and CXCL5 expressions in the liver (Figure 7G). These 
results revealed that tumor-derived TGF-β-regulated MDSCs 
FigUre 7 | recruitment of myeloid-derived suppressor cells (MDscs) into livers was regulated by tumor-derived transforming growth factor β 
(TgF-β). (a) Tumor-derived TGF-β contributed to tumor-induced immune suppression in livers. Sex- and age-matched WT mice were either untreated or inoculated 
with B16 cells or sh RNA-transfected stable B16 cells prepared in our laboratory (1 × 106 cells/mouse) and named TB-B16 or TB-sh B16, respectively. After 15 days 
posttumor inoculations, mice were challenged with concanavalin A; 12 h later, serum alanine aminotransferase levels were analyzed. Results from one of three 
independent experiments are shown (n = 8). (B) Recruitment of MDSCs into livers was dependent on tumor-derived TGF-β. Three groups of mice, as described 
above after day 15 posttumor inoculations, were used for percentage analysis of CD11b+Gr1+ MDSCs through flow cytometry (n = 6). (c) One representative FACS 
plot in panel (B) is shown. (D) Tumor-derived TGF-β elevated expression of CXCLs in the liver. Liver tissues collected from the three groups of mice as shown above 
were used for analyzing mRNA levels of CXCLs via quantitative real-time PCR (n = 3). (e) WT mice were intraperitoneally injected 1 µg rmTGF-β 3 h prior to sacrifice. 
Then WT, TB (B16), TB (sh B16), and WT injected rmTGF-β were sacrificed for analyzing the percentage of CD11b+Gr1+ MDSCs through flow cytometry (n = 3).  
(F) One representative FACS plot in panel (e) is shown. (g) Liver tissues collected from the four groups of mice in panel (e) were used for analyzing mRNA levels of 
CXCLs via quantitative real-time PCR (n = 3).
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recruitment into the liver via promoting CXCL1, CXCL2, and 
CXCL5 expressions in livers.
DiscUssiOn
One of the biggest challenges for curing cancer is to fully under-
stand the molecular mechanisms of how tumor cells escape from 
immune surveillance. It has been well documented that growing 
tumor cells release suppressing factors, which in turn creates spe-
cial microenvironment that not only promotes tumor growth but 
also blocks immune clearance (35, 36). However, the underlying 
mechanisms concerning remote growing tumor-inducing organ-
specific immune suppression are completely elusive. In this study, 
we demonstrated that remote growing tumor cells induced liver 
immune suppression through enhancing both the recruitment of 
MDSCs into liver tissues and their suppressive function on NKT 
cells.
One of the critical findings from our research determined 
the important role of MDSCs in inducing liver immune sup-
pression. It has been well documented that upon subcutaneous 
tumor inoculation, large amounts of MDSCs flow into the liver 
(37). We demonstrated that increased numbers of MDSCs were 
responsible for immune suppression against Con A-induced 
hepatitis, confirmed by observations that depletion of these cells 
by anti-Gr1 antibodies restored Con A-induced liver inflam-
mation, whereas adoptive transferring MDSCs from TB mice 
restrained Con A-triggered liver injury. It has to be emphasized 
that although the numbers of CD4+ Foxp3+ Tregs were also 
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increased significantly in TB mice in comparison to those in WT 
mice, neither depletion nor adoptive transferring of Tregs was 
able to alter Con A-induced hepatitis, supporting our conjecture 
that accumulated MDSCs suppressed liver immune responses. 
These Tregs might be recruited or locally expanded with the fac-
tors secreted by MDSCs. It would be interesting to examine the 
interaction between these two sets of immune-suppressive cells 
for a more desirable understanding of the molecular mechanisms 
of tumor-mediated immune suppression.
Myeloid-derived suppressor cells have broad suppressive 
functions on many cell types. However, the underlying mecha-
nisms for these cells to trigger liver immune suppression have 
not been elucidated. Con A-induced liver injury is a well-studied 
model, and both CD4+ T cells and NKT cells play important 
roles in mediating liver inflammation through producing IFN-γ. 
Our next important finding was clarifying the purpose of NKT 
cells, not CD4+ T cells, as the target of MDSCs in the liver. We 
observed that the numbers of IFN-γ-producing NKT cells were 
significantly reduced in TB mice in comparison with those in 
WT mice, and depletion of MDSCs restored the ability of NKT 
cells to produce IFN-γ. Consistently, adoptive transferring of 
MDSCs from TB mice inhibited IFN-γ production by NKT cells. 
In contrast, CD4+ T cells from all these experimental condi-
tions showed no significant changes in their ability to produce 
IFN-γ. Therefore, we concluded that MDSCs recruited into the 
liver actively suppressed the function of NKT cells, resulting 
in liver immune suppression. Which functional molecules are 
essential for the suppression function of MDSCs on NKT cells? 
Importantly, we emphasized that interaction between MDSCs 
and NKT cells required cell contact, and the suppression effect 
was significantly blocked by anti-TGF-β antibodies. Interestingly, 
recombinant TGF-β1 failed to suppress the production of IFN-γ 
by NKT cells. Our concluding results were that membrane-bound 
TGF-β mediated the suppression function of MDSCs on NKT 
cells through cell contact-dependent mechanisms. These were 
consistent with a previous report that determined MDSCs induce 
NK cell anergy though membrane-bound TGF-β (10). The target 
of these membrane-bound TGF-β and downstream signaling 
pathways are unclear at the present time. It is also worth further 
investigating why the membrane-bound TGF-β has no effect on 
CD4+ T cells. Understanding the selectivity of each suppression 
molecules released from these negative regulators will lead to 
better designing therapeutics against these targets.
It has been observed and further confirmed that TB mice 
induced an influx of MDSCs into the liver. However, the 
underlying molecular mechanisms for this process are not fully 
understood. We determined that tumor-derived TGF-β played an 
important role in this influx, evidenced by the fact that inocula-
tion of shRNA-TGF-β transfected stable cell line previously 
prepared (26) significantly reduced the accumulation of MDSCs 
into the liver. Furthermore, we elucidated that knockdown 
TGF-β from tumor cells significantly reduced the expression of 
chemokines (CXCL1, 2, and 5) in liver tissues, resulting in much 
less influx of MDSCs into the liver. This hypothesis was further 
confirmed by the fact that inoculation of B16 tumor cells into the 
CXCR2−/− mice significantly blocked the recruitment of MDSCs 
into the liver. In summary, our results established a critical role of 
tumor-derived TGF-β in triggering the influx of MDSCs into the 
liver through facilitating the interaction between the CXCL1/2/5 
and the CXCR2.
Interestingly, there was a report that MDSCs in TB mice pro-
moted Con A-induced hepatitis (38), although the report does not 
clarify tumor sizes and days of posttumor inoculations when Con 
A was administered. How is the discrepancy explained between 
our results and those in the report? One possible explanation is 
the different intestinal microbiota, resulting from various mice 
sources and facilities in which they were hosted (39, 40). This is 
not the first time that phenotype differ from each other, when 
hosted in different environments. For example, our laboratory 
showed a much worse Con A-induced hepatitis in IL-17A−/− 
mice, which differed dramatically from the results published in 
the US laboratories (20, 41). We cannot exclude other possibilities 
that tumor cells were used and their tumor sizes when Con A was 
injected.
In summary, we defined a critical role of MDSCs in induc-
ing liver immune suppression in the TB hosts and emphasized 
the significance of targeting these cells in restoring antitumor 
immunity.
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